Title:
アデノシン受容体拮抗薬
Document Type and Number:
Japanese Patent JP7299411
Kind Code:
B2
Abstract:
A compound represented by formula (I) and a pharmaceutical composition thereof. The compound represented by formula (I) can be used as an adenosine receptor inhibitor, in particular, A2A and/or A2B inhibitors, for example, can be used for preventing or treating diseases related to A2A and/or A2B activity or expression level.
Inventors:
Yu, Ji Young
Liu, Shifen
Si, Youngkwang
Liu, Shifen
Si, Youngkwang
Application Number:
JP2022506115A
Publication Date:
June 27, 2023
Filing Date:
July 29, 2020
Export Citation:
Assignee:
XIAMEN BIOTIME BIOTECHNOLOGY CO., LTD.
International Classes:
C07D498/04; A61K31/519; A61K39/395; A61K45/00; A61P25/00; A61P31/12; A61P35/00; A61P35/02; A61P37/06; A61P43/00
Foreign References:
| WO2018161910A1 | ||||
| CN105985354A |
Attorney, Agent or Firm:
Arga Patent Office
Previous Patent: Heater assembly and aerosol generation system
Next Patent: PRETREATMENT OF COATING SURFACE OF AUTOMOBILE AND THE LIKE
Next Patent: PRETREATMENT OF COATING SURFACE OF AUTOMOBILE AND THE LIKE